Trump administration explores Tylenol's potential link to autism amid ongoing debates

The Trump administration suggested a possible link between Tylenol use during pregnancy and increased autism risk, prompting the FDA to consider updating labels, despite mixed scientific evidence and ongoing support from medical groups for Tylenol's safety during pregnancy. The administration also announced plans to review a drug called leucovorin for autism symptoms and controversially hinted at vaccine schedule links to autism, contradicting established research.